The Janus face of immunity: how anti-tumor immunity leads to autoimmunity in paraneoplastic neurological diseases
The Janus face of immunity: how anti-tumor immunity leads to autoimmunity in paraneoplastic neurological diseases
![PDF) Petr Zemanek: The Origins of Pharyngealization in Semitic (Praha, 1996) | Petr Zemánek - Academia.edu PDF) Petr Zemanek: The Origins of Pharyngealization in Semitic (Praha, 1996) | Petr Zemánek - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/59083826/mini_magick20190430-24680-1h94tkj.png?1556612531)
PDF) Petr Zemanek: The Origins of Pharyngealization in Semitic (Praha, 1996) | Petr Zemánek - Academia.edu
![BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool](https://mms.businesswire.com/media/20170801006281/en/604221/4/AML_infographic_8117---FINAL.jpg)